Constellation Pharmaceuticals
Clinical trials sponsored by Constellation Pharmaceuticals, explained in plain language.
-
New pill targets tough blood cancers in major trial
Disease control CompletedThis study tested a new oral drug called pelabresib for people with advanced blood cancers like myelofibrosis. The first part aimed to find a safe dose. The second part tested if pelabresib, given alone or with another drug (ruxolitinib), could shrink enlarged spleens, reduce the…
Phase: PHASE1, PHASE2 • Sponsor: Constellation Pharmaceuticals • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New hope for men with Tough-to-Treat prostate cancer
Disease control CompletedThis study tested a new oral drug, CPI-1205, in combination with standard prostate cancer medications (enzalutamide or abiraterone/prednisone). It involved 175 men whose advanced prostate cancer had spread and was no longer responding to standard hormone therapy. The goal was to …
Phase: PHASE1, PHASE2 • Sponsor: Constellation Pharmaceuticals • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC